ACİL SERVİSTE İZLENEN KRONİK OBSTRÜKTİF AKCİĞER HASTALIĞI VE AKCİĞER KANSERİ OLAN OLGULARIN ÖZELLİKLERİ
Acil servise başvuran kronik obstrüktif akciğer hastalığı (KOAH) ve akciğer kanseri birlikteliği olan olguların genel özelliklerini değerlendirmek. Hastanemiz acil servisine Ocak 2007-Haziran 2007 tarihleri arasında başvuran KOAH ve akciğer kanseri birlikteliği olan 86 olgunun kayıtları retrospektif olarak incelendi. Çalışmaya alınan 86 olgunun 6 (%6.9)'sı kadın, 80'i (%93.1) erkek olup yaş ortalaması 65.3 (37- 81) idi. Olgularn 76 (%88.3)'sı sigara içicisiydi ve ortalama 57.4 (0-150) paket/yılı sigara kullanma öyküsü vardı. Olgularımızda saptanan en sık semptomlar nefes darlığı (%100), öksürük (%88.3) ve balgam çıkarma (%40.6) idi. Daha az sıklıkta kilo kaybı (%40.6), göğüs ağrısı (%33.7) ve hemoptizi (%16.2) izlendi.Radyolojik olarak sıklıkla kitle lezyonu (%97.6), mediastinal ve/ veya hiler lenfadenopati (%83.7) ve atelektazi (%18.6) saptandı. Lezyonların en sık sağ üst lobda (%33.7) yerleştiği, bunu sağ hilus (%22.1) ve sol üst lobun (%20.9) izlediği görüldü. Patolojik tanı 43 (%36.9) olguda küçük hücreli dışı akciğer karsinomu (KHDAK), 14(%12.04) olguda squamöz hücreli akciğer karsinomu, 10 (%8.6) olguda adeno karsinomu, 1 olguda da büyük hücreli akciğer karsinomu ve 14 %16.4) olguda küçük hücreli akciğer karsinomu (KHAK) idi, 4 (%4.8) olguda patolojik tanıya ulaşılamadı. Olguların büyük çoğunluğu (63 olgu, %73.2) lokal ileri ve ileri evre hastalığa sahipti. Olguların 36'sına (%41.8) kemoterapi, 15'ine (%17.5) radyoterapi, 16Ôsına (%18.6) kemoterapi ve radyoterapi, 4'üne (%4.8) cerrahi tedavi uygulanmış olup, 15(%17.5) olgu semptomatik tedavi ile izlenmekteydi. KOAH'lı akciğer kanseri olgularının en sık acil başvuru semptomu nefes darlığı ve en sık acil başvuru nedeni solunum yetmezliği idi.
CHARACTERISTICS OF THE LUNG CANCER CASES WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE FOLLOWED IN EMERGENCY ROOM
To evaluate the characteristics of the cases with chronic obstructive pulmonary disease (COPD) and lung cancer concurrently referred to emergency room. The data of 86 cases referred to emergency service with COPD and lung cancer concurrently between the dates of January and June 2007 were evaluated retrospectively. 80(93.1%) of cases were men and six (6.9%) were women, mean age was 65.3years(37-81). Seventy-six of cases (88.3%) were smokers. The most frequent symptom for referral to emergency room was dyspnea and it was present in all cases. Cough (88.3%), sputum expectoration (40.6%) and weight loss (40.6%) were other the most common symptoms. The most frequent radiological lesions were mass lesion (97.6%) and hilar and/or mediastinal lenfadenopathy (83.7%). Diagnosis of lung cancer was based on histopathology in 82 cases (95.2%) and clinic-radiologic findings dosyain 4 cases (4.8%). The most common cancer type was non small cell lung cancer (NSCLC) (n:43, 36.9%). 14(12.04%) caseses were squamöz lung cancer, 10 cases were adenocarsinoma and 14 cases were small cell lung carcinoma. When assessed in terms of organ metastasis, it was observed that the most frequent one was adrenal metastasis (8.0%). Chemotherapy was performed in 36 (41.8%) cases, radiotherapy in 15 (17.5%), surgery in 4 (4.8%) and 15 (17.5%) subjects were followed by symptomatic therapy. The most frequent symptom for referral was dyspnea and the most frequent cause for referral was respiratory insufficiency in COPD-patients with lung cancer.
___
- 1. Pauwels RA, Buist AS, Calverley PM, et al.
Global strategy for the diagnosis, management,
and prevention of chronic obstructive pulmonary
disease. NHLBI/WHO Global Initiative for
Obstructive Lung Disease (GOLD) Workshop
Summary. Am J Respir Crit Care Med 2001;
163: 1256-76.
- 2 Institute; NIH publication nr 03-5229. [NHLBI]
National Heart, Lung, and Blood Institute Data
Fact Sheet Chronic obstructive pulmonary
disease (COPD). Bethesda, Maryland. US Dept
Public Health and Human Services, National
Institute of Health, National Heart, Lung, and
Blood. 2003.
- 3. Petty TL. Are COPD and Lung Cancer Two
Manifestations of the Same Disease? Chest
2005; 128; 1895-7.
- 4. Mannino DM, Aguayo SM, Petty TL, Redd SC.
Low lung function and incident lung cancer
in the United States: data from the First
National Health and Nutrition Examination Survey follow-up. Arch Intern Med 2003; 163:
1475-80.
- 5. Tockman MS, Anthonisen NR, Wright EC,
Donithan MG. Airways obstruction and the
risk for lung cancer. Ann Intern Med 1987;
106: 512–8.
- 6. Lange P, Nyboe J, Appleyard M, Jensen G,
Schohr P. Ventilatory function and chronic
mucus hypersecretion as predictors of death
from lung cancer. Am Rev Respir Dis 1990;
141: 613–7.
- 7. Schwartz AG, Cote ML, Wenzlaff AS, Van Dyke A,
Chen W, Ruckdeschel JC, Gadgeel S, Soubani
AO. Chronic obstructive lung diseases and
risk of non-small cell lung cancer in women.
J Thorac Oncol 2009; 4(3): 291-9.
- 8. Wasswa-Kintu S, Gan WQ, Man SF, Pare PD,
Sin DD. Relationship between reduced forced
expiratory volume in one second and the
risk of lung cancer: a systematic review and
meta-analysis. Thorax 2005; 60(7): 570-5.
- 9. Wu AH, Yu MC, Thomas DC, Pike MC,
Henderson BE. Personal and family history
of lung disease as risk factors for adenocarcinoma
of the lung. Cancer Res 1988;
48(24 Pt 1): 7279-84.
- 10. Cohen BH, Diamond EL, Graves CG, Kreiss P,
Levy DA, Menkes HA, Permutt S, Quaskey S,
Tockman MS. A common familial component
in lung cancer and chronic obstructive
pulmonary disease. Lancet 1977; 10; 523-6.
- 11. Demir A, Büyükflirin M, Polat G ve ark. KOAH
çad›r›nda ölçülen SFT sonuçlar› ve KOAH risk
faktörlerinin de¤erlendirilmesi. Türk Toraks
Dergisi 2006;7: 23-8.
- 12. Mannino DM. Chronic obstructive pulmonary
disease:definition and epidemiology. Respir
Care 2003; 48: 1185-91; discussion 1191-3.
- 13. Sherman S, Guidat CE. Feasibility of thoracotomy
for lung cancer in the elderly. JAMA
1987; 258: 927-30.
- 14. Halilçolar H, Tatar D, Ertu¤rul G ve ark.
Epidemiyoloji. Akkoçlu A, Öztürk C. Akci¤er
kanseri multidisipliner yaklafl›m. Toraks Kitaplar›
Say›: 1 Bilimsel T›p Yay›nevi; Ankara
1999: 7-14.
- 15. Viegi G, Pedreschi M, Pistelli F, et al. Prevalance
of airways obstruction in a general
population: European Respiratory Society vs
American Thoracic Society definition. Chest
2000; 117: 339-45.
- 16. Mannino DM, Homa DM, Akinbami LJ, et al
.Chronic obstructive pulmonary disease
surveillance: United States,1971- 2000. Mor
Mortal Wkly Rep CDC Surveill Summ 2002;
511-6.
- 17. KOAH Çal›flma Grubu. Toraks Derne¤i Kronik
Obstruktif Akci¤er Hastal›¤› Tan› ve Tedavi
Rehberi, Toraks Dergisi 2000; 1(Ek 2).
- 18. Beckles MA, Spiro SG, Colice GL, Rudd RM.
Initial Evaluation of the patient with lung
cancer. Symptoms, signs, laboratory tests,
and paraneoplastic syndromes. Chest 2003;
123: 97-104.
- 19. Bragg DG. The diagnosis and staging of
primary lung cancer. Radiol Clin North Am
1994; 32(1): 1-14.
- 20. Lisa JR, Trinidad S, Rosenblatt MB. Site of
origin histogenesis and cytostructure of
bronchogenic carcinoma. Am J Clin Pathol
1975; 44: 375-8.
- 21. Sakarya ME, Özbay B, Arslan H, Uzun K,
Ceylan E, Ödev K. Akci¤er Kanseri Tan›s›nda
Konvansiyonel Radyografi ve Bilgisayarl›
Tomografi Bulgular›. Van T›p Dergisi 1998;:
5: 161-5.
- 22. Sider L. Radiographic manifestations of primary
bronchogenic carcinoma. Radiol Clin North
Am 1990; 28(3): 583-97.
- 23. Schabath MB, Delclos GL, Martynowicz MM,
Greisinger AJ, Lu C, Wu X, Spitz MR. Opposing
effects of emphysema, hay fever, and
select genetic variants on lung cancer risk.
Am J Epidemiol 2005;16: 412-22.
- 24. Koshiol J, Rotunno M, Consonni D, Pesatori
AC, De Matteis S, Goldstein AM, et al. Chronic
obstructive pulmonary disease and altered
risk of lung cancer in a population-based
case-control study. PLoS One 20098; 4: e7380.
- 25. Janssen-Heijnen ML, Schipper RM, Razenberg
PP, et al. Prevalence of comorbidity in lung
cancer patients and its relationship with
treatment: A population-based study. Lung
Cancer 1998; 21: 105-13.
- 26. Yancik R, Kessler L, Yates JW, et al. The
elderly population: Opportunities for cancer
prevention and detection. Cancer 1988; 62:
1823-8.
- 27. Özgün MA, Karagöz B, Bilgi O, Kandemir
EG, Türken O. Küçük Hücreli D›fl› Akci¤er
Kanserinde Komorbiditenin Prognostik Önemi
ve Di¤er Prognostik Faktörlerle ‹liflkisi UHOD
2009; 19: 63-8.
- 28. Sin DD, Anthonisen NR, Soriano JB, Agusti
AB. Eur Respir J 2006; 28: 1245-57.
- 29. Barnes PJ, Celli BR. Systemic manifestations
and comorbidities of COPD. Eur Respir J 2009;
33: 1165-85.
- 30. Wouters EF. Chronic obstructive pulmonary
disease. 5. Systemic effects of COPD. Thorax
2002; 57: 1067-70.
- 31. Agusti AG, Noguera A, Sauleda J, et al. Systemic
effects of chronic obstructive pulmonary
disease. Thorax 2004; 59: 574-80.
- 32. Çilli A, Özdemir T, Özbulak Ö, Yak›flan A,
Ö¤üfl C. Akci¤er kanserli hastalarda KOAH
birlikteli¤i. Solunum 2003: 5: 20-4.
- 33. Ernam D, Atalay F, Atikcan P. A retrospective
evaluation of 571 lung carcinoma patients.
Turkish Respiratory Journal 2003; 4: 67-9.
- 34 Atikcan P, Pelit A, Bay›z H, Bapay N, Y›lmaz
Turay Ü. Metastazlar›n tedavisi. In: Akkoçlu
A, Öztürk C (eds). Akci¤er Kanseri Multidisipliner
Yaklafl›m. Ankara. Bilimsel T›p Yay›nevi.
1999; 146-54.